Keywords: Tumors (Pre-Treatment), Tumors, Artificial Intelligence, MR Fingerprinting
Motivation: Gadolinium-enhanced MRI is crucial for brain tumor diagnosis, but drawbacks associated with gadolinium-based contrast agents (GBCAs) drive interest in developing alternative imaging methods.
Goal(s): Our goal is to develop a model capable of predicting gadolinium-enhanced MR images that closely resemble those obtained with contrast injection, in terms of tumor enhancement overlap and overall appearance.
Approach: We developed a deep-learning based model that can be trained with pre-contrast MRF maps, synthetic contrasts, and/or clinical images and predict gadolinium-enhanced MR images.
Results: The models obtained competitive enhancing tumor overlap values (0.599, 0.603, 0.622) and quantitative metrics (average SSIM=0.944, CC=0.941, and MAE=0.261).
Impact: The clinical use of a deep learning model to obtain gadolinium-enhanced MR images would replace the need for GBCAs, thus eliminating associated problems including longer scan times, higher costs, and certain patient risks.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords